О себе
Suzanne Hendrix, PhD, is a biostatistician and clinical-trial design specialist focused on Alzheimer's disease and other neurodegenerative disorders. Pentara says she has led the company since 2008 and has more than 30 years of experience across CROs and pharmaceutical companies, with over 150 peer-reviewed publications. She also serves as an advisor to Propel Bio Partners, contributing drug development and regulatory strategy expertise.
Области интересов
biotechneuroscienceAlzheimer's diseaseneurodegenerative diseasesclinical trialsbiostatisticsregulatory sciencedrug developmenthealthy aging